Molecular chaperones and neuronal proteostasis

Seminars in Cell & Developmental Biology
Heather L SmithMichael E Cheetham

Abstract

Protein homeostasis (proteostasis) is essential for maintaining the functionality of the proteome. The disruption of proteostasis, due to genetic mutations or an age-related decline, leads to aberrantly folded proteins that typically lose their function. The accumulation of misfolded and aggregated protein is also cytotoxic and has been implicated in the pathogenesis of neurodegenerative diseases. Neurons have developed an intrinsic protein quality control network, of which molecular chaperones are an essential component. Molecular chaperones function to promote efficient folding and target misfolded proteins for refolding or degradation. Increasing molecular chaperone expression can suppress protein aggregation and toxicity in numerous models of neurodegenerative disease; therefore, molecular chaperones are considered exciting therapeutic targets. Furthermore, mutations in several chaperones cause inherited neurodegenerative diseases. In this review, we focus on the importance of molecular chaperones in neurodegenerative diseases, and discuss the advances in understanding their protective mechanisms.

References

Apr 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·K LiberekM Zylicz
Jul 5, 1987·Nature·J Ellis
May 19, 1998·Cell Stress & Chaperones·M E Cheetham, A J Caplan
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·M G SpillantiniM Goedert
Mar 10, 2000·Science·P Kazemi-Esfarjani, S Benzer
Mar 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·A WyttenbachD C Rubinsztein
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·P J MuchowskiF U Hartl
Jan 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Fei DouHuaxi Xu
Mar 27, 2004·The Journal of Biological Chemistry·Jochen KluckenPamela J McLean
May 4, 2004·Nature Genetics·Joy IrobiVincent Timmerman
Jun 17, 2004·Journal of Neurochemistry·Makoto UrushitaniRyosuke Takahashi
Nov 24, 2004·The Journal of Biological Chemistry·Pavan K AuluckNancy M Bonini
Feb 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Namita AgrawalJ Lawrence Marsh
Jun 7, 2005·Current Biology : CB·Britta WesthoffMichael E Cheetham
Jul 27, 2005·Biochemical Society Transactions·B KalmarL Greensmith
Jul 30, 2005·The Journal of Biological Chemistry·Mitsuaki FujimotoAkira Nakai
Aug 12, 2005·Journal of Neurochemistry·Carine ClerenM Flint Beal
Aug 23, 2005·Journal of Neurochemistry·Naruhiko SaharaAkihiko Takashima
Sep 13, 2005·Journal of Human Genetics·Kazuki KijimaKiyoshi Hayasaka
Nov 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Masahisa KatsunoGen Sobue
Feb 25, 2006·Experimental Neurology·Paul SharpJacqueline de Belleroche
Mar 28, 2006·Biochemical and Biophysical Research Communications·Shingo KoyamaTakeo Kato
Jun 8, 2006·Annual Review of Biochemistry·Laurence H Pearl, Chrisostomos Prodromou
Sep 16, 2006·The Journal of Biological Chemistry·Christopher G EvansJason E Gestwicki
Nov 4, 2006·Biochemical and Biophysical Research Communications·Tiago Fleming OuteiroPamela J McLean
Feb 17, 2007·The Journal of Clinical Investigation·Chad A DickeyLeonard Petrucelli

❮ Previous
Next ❯

Citations

Mar 15, 2016·Frontiers in Immunology·Daming ZuoXiang-Yang Wang
Nov 26, 2015·Trends in Cell Biology·Chengkai Dai, Stephen Byers Sampson
Apr 29, 2015·Hormones and Behavior·Margaret M McCarthyKatherine E Kight
Apr 3, 2016·Brain Research·Navit Ogen-ShternGerardo Z Lederkremer
May 16, 2015·Seminars in Cell & Developmental Biology·Alan Morgan, Robert D Burgoyne
Sep 24, 2016·Molecular Neurobiology·Sara D ReisJorge M A Oliveira
Apr 6, 2004·Molecular and Cellular Endocrinology·Katsuya TagoKazue Takano
Dec 22, 2016·European Journal of Human Genetics : EJHG·Catalina VasilescuChristopher J Carroll
Dec 30, 2016·Human Molecular Genetics·Daniele OttavianiMaria Ruzzene
Sep 14, 2017·International Journal of Molecular Sciences·Noopur BhoreYung-Feng Liao
Jan 21, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Parvana Hajieva
Dec 6, 2017·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Christina ZarouchliotiMichael E Cheetham
Nov 15, 2017·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Nicholas U SchwartzLina M Obeid
Jul 13, 2016·Cellular Microbiology·Domenico Azarnia TehranCesare Montecucco
Oct 17, 2016·Essays in Biochemistry·Cheryl Li, Olivia Casanueva
Jul 28, 2020·Genes·Ryan HoganGilbert Bernier
Oct 6, 2020·Frontiers in Cellular Neuroscience·Erin N Lottes, Daniel N Cox
Jan 18, 2017·Cold Spring Harbor Perspectives in Medicine·Margaret M P Pearce, Ron R Kopito
Jul 7, 2017·Frontiers in Molecular Neuroscience·Paola RusminiAngelo Poletti
Oct 18, 2019·Frontiers in Pharmacology·Jack M WebsterLaura J Blair
Dec 27, 2016·Frontiers in Molecular Biosciences·Vincenzo LupoCarmen Espinós
Mar 16, 2017·Translational Neurodegeneration·Patrick SweeneyRobert Hodgson
Aug 6, 2020·International Journal of Molecular Sciences·Jack M WebsterLaura J Blair
Oct 28, 2020·Investigative Ophthalmology & Visual Science·Ke JiangAnand Swaroop
Sep 22, 2019·Neuroscience Letters·Leonardo Pignataro
Nov 21, 2020·International Journal of Molecular Sciences·Ryan P KreiserRyan Limbocker
Feb 8, 2021·Biochimica Et Biophysica Acta. Molecular Cell Research·April L Darling, James Shorter
Sep 16, 2019·Neurological Research and Practice·Alexander P Marsh
May 4, 2021·Frontiers in Cell and Developmental Biology·Shenae L CafeElizabeth G Bromfield

❮ Previous
Next ❯

Related Concepts

Related Feeds

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.